In this TargetCancer Foundation Lunch and Learn Webinar, four rare cancer patients and advocates who are making a powerful impact in the field discussed their personal experiences and insights regarding the importance of advocacy for awareness and progress in the treatment of rare cancers.
TargetCancer Foundation President Kristen Palma was joined by rare cancer patients and advocates Dana Deighton (Director, Communications & Engagement, Melanoma Research Alliance), Katie Doble (Stage 4 Rare Cancer Survivor and Patient Advocate), Naomi Natale (Co-Founder, cureMEC: The Myoepithelial Carcinoma Project) and Suzanne Vincze (Vice President, Max Vincze Foundation) for this important discussion.